Women's Health

Menopause Market Report 2023-2033

Fri, 26 May 2023 15:45:30 +0000

The Menopause Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Demand for Post-Menopause Drugs Owing to Rise in Geriatric Population
Some of the major forces propelling the menopause and post-menopause market include the aging population, rising awareness, technological advancements, and increasing healthcare spending drive demand for new and innovative solutions. With growing awareness about menopause and its symptoms, more women are seeking treatment options. The aging population is growing worldwide, and it is expected that the number of menopausal women will increase in the coming years. This presents a huge market opportunity for menopause drugs.

Lifestyles changes and sedentary habits have led to an increase in menopausal symptoms as women ...

$4,938.00

Women's Health Market Report 2023-2033

Fri, 19 May 2023 11:50:09 +0000

The Women's Health Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The rise in support and initiatives by government and NGOs is boosting the market growth
Globally there has been a rise in awareness of women’s health with all the governments and NGOs supporting through various funding and awareness programs. For instance, in 2021, Office on Women’s Health (OWH) which works with the parent organisation i.e. The U.S. Department of Health and Human Services (HHS) announced an initiative to enhance and improve maternal health data across the country through a US$8 million agreement with Premier Inc. Under this agreement a minimum of 200 would be deployed under evidence based best practices for maternal care. On June 2022, the White House announced the Bide...

$4,938.00

Menopausal Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Tue, 12 Jul 2022 15:44:46 +0000

Summary

Menopausal Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Menopausal Disorders pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Menopausal Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, co...

$2,000.00

Women Infertility Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 17 Jun 2022 15:11:14 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Drugs In Development, 2022, provides an overview of the Women Infertility (Women's Health) pipeline landscape.

Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due to damage of fallopian tubes, ovulation disorders (polycystic ovary syndrome) and endometriosis. Symptoms include abnormal periods, weight gain, back pain, pelvic pain, and cramping. Risk factor of infertility includes smoking tobacco, using alcohol, being overweight, being exposed to toxins, certain medical conditions, including tumors and chronic illnesses. Treatment includes medications to stimulate ovulation and hormone therapies.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Women Infertility - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Women Infertility (Women's Health), complete with an...

$2,500.00

Global Women Health Care Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception,) - Global Forecast to 2027

Wed, 11 May 2022 11:50:02 +0000

The women’s healthcare market is expected to grow at a CAGR of ~9.78% from 2020 to reach USD 19.8 billion by 2027. The growth of this market is driven by the increasing prevalence of chronic health disorders among women, research & development for advanced products for women’s health, government initiatives to control population and awareness around prevention of unwanted pregnancies. By Drug: Proila accounted for largest market share in 2020 The women’s healthcare market is segmented into EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL and ORTHO TRI-CY LO (28) on the basis of drug. Prolia is expected to account for largest market share among all drugs used in Women’s healthcare. The large share is mainly attributed to use of this drug in postmenopausal osteoporosis and growing population of older women across the globe. By Application: Postmenopausal osteoporosis accounted for largest share in 2020 Based on the application, women’s healthcare market is segmented into hormonal infertility, postmenopausal osteo...

$3,400.00

Contraceptive Devices - Market Insights, Competitive Landscape and Market Forecast-2027

Wed, 27 Apr 2022 14:02:44 +0000

Contraceptives Market By Type (Male Contraceptives, Female Contraceptives), By Product Type (Contraceptive Drugs [Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives {Patches, Gels, Others}], Contraceptive Devices [Condoms, Diaphragms, Cervical Caps, Vaginal Rings, Intrauterine Devices (IUDs), Subdermal Contraceptive Implants]), by geography is expected to grow at a steady CAGR forecast till 2027 owing to increasing awareness about sexually transmitted diseases, rise in government initiatives for population control.

Global Contraceptives Market was valued at USD 24.17 billion in 2021, growing at a CAGR of 5.19% during the forecast period from 2022 to 2027 to reach USD 32.61 billion by 2027. The Contraceptives market is witnessing positive growth owing to the increasing awareness about sexually transmitted diseases, rise in government initiatives for population control, upsurge in unintended pregnancies, technological innovations leading to effective contraception, thereby contributing to the growth of the Contraceptives market during the forecast period...

$4,750.00

Global Women's Health Drugs Market Research Report 2021-2025

Wed, 08 Sep 2021 15:45:00 +0000

Women’s bodies go through major changes throughout their lives, leading to differences in health concerns for varying age groups. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Women's Health Drugs Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Women's Health Drugs market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025. The report firstly introduced the Women's Health Drugs basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s...

$3,200.00

Vasomotor Symptoms of Menopause (Hot Flashes) - Global Clinical Trials Review, H2, 2021

Fri, 03 Sep 2021 16:07:52 +0000

Summary

GlobalData's clinical trial report, “Vasomotor Symptoms of Menopause (Hot Flashes) - Global Clinical Trials Review, H2, 2021" provides an overview of Vasomotor Symptoms of Menopause (Hot Flashes) Clinical trials scenario. This report provides top line data relating to the clinical trials on Vasomotor Symptoms of Menopause (Hot Flashes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision maki...

$2,500.00

Women Infertility - Pipeline Review, H1 2020

Thu, 07 May 2020 13:39:47 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H1 2020, provides an overview of the Women Infertility (Women's Health) pipeline landscape.

Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due to damage of fallopian tubes, ovulation disorders (polycystic ovary syndrome) and endometriosis. Symptoms include abnormal periods, weight gain, back pain, pelvic pain, and cramping. Risk factor of infertility includes smoking tobacco, using alcohol, being overweight, being exposed to toxins, certain medical conditions, including tumors and chronic illnesses. Treatment includes medications to stimulate ovulation and hormone therapies.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Women Infertility - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Women Infertility (Women's Health), complete with analys...

$2,000.00

Post Menopausal Osteoporosis - Pipeline Review, H1 2020

Thu, 07 May 2020 13:13:49 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H1 2020, provides an overview of the Post Menopausal Osteoporosis (Metabolic Disorders) pipeline landscape.

Postmenopausal osteoporosis is the most common form of osteoporosis. It affects many women after menopause. Symptoms include back pain, loss of height, or spinal deformities such as stooped posture. Risk factors include age, gender, family history, bone structure and body weight. Treatment includes hormone replacement therapy (HRT) and vitamin D analogues.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Post Menopausal Osteoporosis (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descri...

$2,000.00

Women Infertility Global Clinical Trials Review, H2, 2018

Fri, 07 Dec 2018 15:32:55 +0000

Summary

GlobalData's clinical trial report, “Women Infertility Global Clinical Trials Review, H2, 2018" provides an overview of Women Infertility clinical trials scenario. This report provides top line data relating to the clinical trials on Women Infertility. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain compe...

$2,500.00

Vasomotor Symptoms of Menopause (Hot Flashes) Global Clinical Trials Review, H2, 2018

Thu, 06 Dec 2018 11:06:52 +0000

Summary

GlobalData's clinical trial report, “Vasomotor Symptoms of Menopause (Hot Flashes) Global Clinical Trials Review, H2, 2018" provides an overview of Vasomotor Symptoms of Menopause (Hot Flashes) clinical trials scenario. This report provides top line data relating to the clinical trials on Vasomotor Symptoms of Menopause (Hot Flashes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision m...

$2,500.00

Women Infertility - Pipeline Review, H2 2018

Thu, 29 Nov 2018 13:32:16 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H2 2018, provides an overview of the Women Infertility (Women's Health) pipeline landscape.

Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due to damage of fallopian tubes, ovulation disorders (polycystic ovary syndrome) and endometriosis. Symptoms include abnormal periods, weight gain, back pain, pelvic pain, and cramping. Risk factor of infertility includes smoking tobacco, using alcohol, being overweight, being exposed to toxins, certain medical conditions, including tumors and chronic illnesses. Treatment includes medications to stimulate ovulation and hormone therapies.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Women Infertility - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Women Infertility (Women's Health), complete with analys...

$2,000.00

Post Menopausal Osteoporosis - Pipeline Review, H2 2018

Thu, 29 Nov 2018 13:32:16 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H2 2018, provides an overview of the Post Menopausal Osteoporosis (Metabolic Disorders) pipeline landscape.

Postmenopausal osteoporosis is the most common form of osteoporosis. It affects many women after menopause. Symptoms include back pain, loss of height, or spinal deformities such as stooped posture. Risk factors include age, gender, family history, bone structure and body weight. Treatment includes hormone replacement therapy (HRT) and vitamin D analogues.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Post Menopausal Osteoporosis (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descri...

$2,000.00

Female Contraception - Pipeline Review, H2 2017

Thu, 18 Jan 2018 15:45:29 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Contraception - Pipeline Review, H2 2017, provides an overview of the Female Contraception (Women's Health) pipeline landscape.

Contraception (birth control) prevents pregnancy by interfering with the normal process of ovulation, fertilization, and implantation. There are many contraceptive methods which include implants and injections, intrauterine devices (IUDs), pills and vaginal rings, barrier methods, sterilization and natural methods. Contraception generally work by preventing sperm from reaching and fertilizing an egg (barrier and IUD methods), preventing an egg from being released every month (hormones), blocking the reproductive function (sterilization) and preventing a fertilized egg from implanting in the uterus (hormones).

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Female Contraception - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics unde...

$2,000.00

Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017

Thu, 18 Jan 2018 15:45:29 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017, provides an overview of the Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) pipeline landscape.

Vasomotor symptoms of menopause include hot flashes or night sweats that result from sudden opening of the blood vessels close to the skin, usually due to hormonal fluctuations in menopause and perimenopause. These symptoms are caused due to some medications, estrogen withdrawal, thyroid disease, diabetes, hyperhidrosis, anxiety and panic disorders, obesity, hormonally active tumors, chronic infections and neurological disorders.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health), complete with analysi...

$2,000.00

Male Contraception Global Clinical Trials Review, H2, 2017

Thu, 18 Jan 2018 13:06:38 +0000

Summary

GlobalData's clinical trial report, “Male Contraception Global Clinical Trials Review, H2, 2017" provides an overview of Male Contraception clinical trials scenario. This report provides top line data relating to the clinical trials on Male Contraception. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain co...

$2,500.00

Post Menopausal Osteoporosis - Market Insights, Epidemiology and Market Forecast-2023

Tue, 25 Apr 2017 20:08:12 +0000

Note*: This report requires 5-10 business days to complete. DelveInsight’s Post Menopausal Osteoporosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Post Menopausal Osteoporosis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Post Menopausal Osteoporosis till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Post Menopausal Osteoporosis market. • Identifying patient populations in the global “Post Menopausal Osteoporosismarket to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the best opportunities for Post Meno...

$4,950.00

Female Contraception - Pipeline Review, H2 2016

Fri, 07 Apr 2017 13:51:23 +0000

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Female Contraception Overview 9
Therapeutics Development 10
Pipeline Products for Female Contraception - Overview 10
Pipeline Products for Female Contraception - Comparative Analysis 11
Female Contraception - Therapeutics under Development by Companies 12
Female Contraception - Therapeutics under Investigation by Universities/Institutes 13
Female Contraception - Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Female Contraception - Products under Development by Companies 17
Female Contraception - Products under Investigation by Universities/Institutes 19
Female Contraception - Companies Involved in Therapeutics Development 20
Addex Therapeutics Ltd 20
Agile Therapeutics Inc 21
ANI Pharmaceuticals Inc 22
Bayer AG 23
Evofem Inc 24
Hervana Ltd 25
Mithra Pharmaceuticals SA 26
Orbis Biosciences Inc 27
Teva Pharmaceutical...

$2,000.00

Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2017

Wed, 05 Apr 2017 15:52:18 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Hypoactive Sexual Desire Disorder – Pipeline Review, H1 2017, provides an overview of the Female Hypoactive Sexual Desire Disorder (Women's Health) pipeline landscape.

Hypoactive sexual desire disorder (HSDD) is an absence of sexual fantasies and desire for sexual activity. The predisposing factors include anxiety, depression, androgen deficiencies, and chronic debilitating illnesses, such as chronic renal failure, hyper-prolactinaemia and hypo-hyperthyroid states. Treatment includes antidepressant and hormone therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Female Hypoactive Sexual Desire Disorder – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Female Hypoactive Sexual Desire Disorder (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (R...

$2,000.00

Premenstrual Syndrome - Pipeline Review, H1 2017

Wed, 05 Apr 2017 15:52:18 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Premenstrual Syndrome – Pipeline Review, H1 2017, provides an overview of the Premenstrual Syndrome (Women's Health) pipeline landscape.

Premenstrual syndrome (PMS) is a collection of physical and emotional symptoms related to a woman's menstrual cycle. Premenstrual syndrome has a wide variety of symptoms, including mood swings, tender breasts, food cravings, fatigue, irritability and depression.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Premenstrual Syndrome – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Premenstrual Syndrome (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and...

$2,000.00

Women Infertility - Pipeline Review, H1 2017

Wed, 05 Apr 2017 15:52:18 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility – Pipeline Review, H1 2017, provides an overview of the Women Infertility (Women's Health) pipeline landscape.

Infertility is the inability to get pregnant after a year of unprotected intercourse. Female infertility can be also be caused by a number of factors, which include damage to fallopian tubes, hormonal causes, cervical causes, uterine causes, unexplained infertility. Treatment depends on the cause of infertility.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Women Infertility – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Women Infertility (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and developme...

$2,000.00

European Market Report for Transcervical Female Sterilization 2016 - MedCore

Tue, 28 Mar 2017 10:08:52 +0000

Female sterilization is a permanent form of birth control, requiring invasive surgery to reverse. Female sterilization prevents ova from coming down the fallopian tubes and blocks fertilization by sperm. There are different procedures to perform female sterilization, including tubal ligation, mechanical blockage with a clip or band, bipolar electrocoagulation or transcervical implants. In this report, only the transcervical implant market is covered....

$3,995.00

Post Menopausal Osteoporosis - Pipeline Review, H1 2016

Tue, 31 May 2016 09:45:03 +0000

Summary

Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H1 2016’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Post Menopausal Osteoporosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Post Menopausal Osteoporosis and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical tria...

$2,000.00